Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Pharma Fund · Direct ✕Bank of India Business Cycle Fund · Direct ✕

Growth of ₹10,000

Basics

Nippon India Pharma FundBank of India Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseNippon IndiaBank of India
NAV₹666.3420₹10.1100
NAV date20 Nov 202620 Nov 2026
History13.9 years2.2 years
Expense ratio1.0%1.4%
Stars★★★★★Not rated
Growth Score75.20—

Returns

Nippon India Pharma FundBank of India Business Cycle Fund
1 month+11.40%+5.42%
3 months+3.74%+1.00%
6 months+8.55%+9.30%
YTD+16.94%+10.73%
1 year+15.26%+7.10%
3 years (CAGR)+17.96%—
5 years (CAGR)+15.40%—
10 years (CAGR)+16.61%—
Since launch+17.63%+0.40%

Risk

Nippon India Pharma FundBank of India Business Cycle Fund
Volatility14.1%—
Downside volatility9.0%—
Sharpe0.81—
Sortino1.28—
Calmar1.22—
Return / risk1.27—
Deepest fall−24.02%−25.21%
Days to recover445—
Below its high+0.00%−3.44%

Against benchmark

Nippon India Pharma FundBank of India Business Cycle Fund
Alpha−1.86%—
Beta0.89—
R²89.5%—
Up capture85.2%—
Down capture88.7%—
Tracking error4.8%—
Information ratio−0.69—
Treynor0.12—

Consistency

Nippon India Pharma FundBank of India Business Cycle Fund
Best 1-year+90.70%+12.64%
Middle 1-year+13.13%+1.89%
Worst 1-year−15.12%−13.31%
1-year periods with a loss23.2%41.7%
Middle 3-year+19.82%—
Positive months63.9%—
Best day+3.40%+4.23%
Worst day−3.21%−3.87%
Worst 5% day−1.38%−1.77%
Positive days53.7%49.7%
NAVs a year247247

SIP of ₹10,000 a month

Nippon India Pharma FundBank of India Business Cycle Fund
5-year XIRR+18.24%—
5-year value₹9,54,076—
3-year XIRR+14.26%—
1-year XIRR+22.08%+15.54%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth